These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11570109)

  • 1. Exercise in the reduction of cardiovascular events. Lessons from epidemiologic trials.
    Gibbons LW; Clark SM
    Cardiol Clin; 2001 Aug; 19(3):347-55. PubMed ID: 11570109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular prevention: new study, new guidelines. The effort keeping the heart healthy].
    Einecke D
    MMW Fortschr Med; 2004 Sep; 146(38):4-6, 8. PubMed ID: 15532422
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular diseases in Brazil: premature mortality, risk factors and priorities for action. Comments on the preliminary results from the Brazilian National Health Survey (PNS), 2013.
    Lotufo PA
    Sao Paulo Med J; 2015; 133(2):69-72. PubMed ID: 26018879
    [No Abstract]   [Full Text] [Related]  

  • 5. Physical activity levels and coronary heart disease. Analysis of epidemiologic and supporting studies.
    Leon AS
    Med Clin North Am; 1985 Jan; 69(1):3-20. PubMed ID: 3883077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
    Yang HT; Lee M; Hong KS; Ovbiagele B; Saver JL
    Eur J Intern Med; 2012 Dec; 23(8):745-54. PubMed ID: 22884409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
    Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
    Keech A; Colquhoun D; Best J; Kirby A; Simes RJ; Hunt D; Hague W; Beller E; Arulchelvam M; Baker J; Tonkin A;
    Diabetes Care; 2003 Oct; 26(10):2713-21. PubMed ID: 14514569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants for vascular disease.
    Rimm EB; Stampfer MJ
    Med Clin North Am; 2000 Jan; 84(1):239-49. PubMed ID: 10685137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and secondary prevention of cardiovascular disease in the elderly.
    García-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic prevention of cardiovascular diseases. Summary and perspectives].
    Kübler W
    Z Kardiol; 1992; 81 Suppl 4():221-2. PubMed ID: 1290302
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical activity in the cardiac patient.
    Sellier P
    J Cardiovasc Pharmacol; 1995; 25 Suppl 1():S9-14. PubMed ID: 7752669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measure of fitness and physical activity related to cardiovascular diseases and death].
    Apor P
    Orv Hetil; 2011 Jan; 152(3):107-13. PubMed ID: 21205610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years.
    Lamm G
    Eur Heart J; 1981 Aug; 2(4):269-80. PubMed ID: 7028485
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial risks and cardiovascular diseases.
    Frasure-Smith N; Lespérance F
    Can J Cardiol; 1999 Dec; 15 Suppl G():93G-7G. PubMed ID: 10692666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reducing cholesterol in cardiovascular rehabilitation--exercise versus drug therapy].
    Halle M; Berg A; Keul J
    Wien Klin Wochenschr; 1997; 109 Suppl 2():29-32. PubMed ID: 9340920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 20. Olive oil, the mediterranean diet, and cardiovascular health.
    Huang CL; Sumpio BE
    J Am Coll Surg; 2008 Sep; 207(3):407-16. PubMed ID: 18722947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.